PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis - sprookjes - yvandenbroek - TriplyDB

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

http://www.wikidata.org/entity/Q23914949

about

PI3K/AKT/mTOR Pathway in Angiogenesis Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations Hypoxia-independent drivers of melanoma angiogenesis Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway PI3K/PTEN signaling in angiogenesis and tumorigenesis Novel non-AR therapeutic targets in castrate resistant prostate cancer HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy Insulin promotes glucose consumption via regulation of miR-99a/mTOR/PKM2 pathway Inhibition of phosphoinositide 3-kinase/Akt pathway decreases hypoxia inducible factor-1α expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cells Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response Antisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cells Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice The PI3K/Akt signaling pathway exerts effects on the implantation of mouse embryos by regulating the expression of RhoA Concurrent Down-Regulation of PTEN and NKX3.1 Expression in Iranian Patients with Prostate Cancer Nickel and the microbial toxin, MALP-2, stimulate proangiogenic mediators from human lung fibroblasts via a HIF-1alpha and COX-2-mediated pathway miTALOS: analyzing the tissue-specific regulation of signaling pathways by human and mouse microRNAs The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells Triiodothyronine increases mRNA and protein leptin levels in short time in 3T3-L1 adipocytes by PI3K pathway activation α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndrome Interleukin-32 expression in the pancreas Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2 Nuclear PTEN levels and G2 progression in melanoma cells Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells The Role of PTEN in Tumor Angiogenesis CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation Akt mediates metastasis-associated gene 1 (MTA1) regulating the expression of E-cadherin and promoting the invasiveness of prostate cancer cells KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation Growth inhibition of human gastric adenocarcinoma cells in vitro by STO-609 is independent of calcium/calmodulin-dependent protein kinase kinase-beta and adenosine monophosphate-activated protein kinase Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1 Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells Sustained proliferation in cancer: Mechanisms and novel therapeutic targets

P2860

Q21129332-1EE29C76-F7D3-4CF4-A6C0-DAC5EEF39572 Q24304210-7CE2410A-8756-4FD3-88B7-7080CCE39A61 Q24646816-44B1F97B-AB92-4E91-A2C4-7E4FE0F9DEA6 Q27022246-369205DD-6CA5-4030-B679-2BAE73CD9646 Q28382812-3B1F4F5A-BED5-4B99-B294-1C74C87FBBB5 Q28383083-38625104-D170-45FF-91B6-3D1B2915D330 Q28383663-E48E9D15-AD62-497D-BCBA-660FEF34BB78 Q28383826-5A038F75-032A-4678-B078-D8D97498E68F Q28384176-00874F3C-1A2A-4C56-AE8D-5E4BDB70E269 Q28384554-F7FF6E27-5A04-4795-8BB2-07E639AA17E8 Q28384680-66FD0E24-3404-470E-8E46-39807397059C Q28384798-55E21C4C-0694-4DAA-BABC-F3BC7205BF9E Q28385231-CD37B109-3662-4223-B506-228B24AB9F4E Q28385532-08B28E3A-3F09-40C4-B6EA-EC3DFFF08028 Q28385885-2C232B03-367D-4DB7-AB2E-D1EB36B6A98B Q28387281-C75E596E-BA2A-4143-B70D-6EA9C9EAB5EC Q28387389-2BEC2043-2282-40AD-BAC8-DFDE58670863 Q28387968-CD40E0FF-1234-4DF6-BCA5-518A3BD7658A Q28388047-CD50BBBA-A92B-443D-A9A0-615639AACCCB Q28388072-D7A88524-EBC5-493E-9324-062D40A7A7C7 Q28388238-07451C30-816D-428E-9574-E99C07EB1DD8 Q28388722-1F6ED05E-130B-4D5F-90E9-C0952FC0A746 Q28388841-F798DB3A-8779-4C6E-A9BE-1047E2C66A28 Q28389681-F5E30E55-9BF7-440E-ABB4-3FD27B425A8A Q28389912-6D52CFE6-F786-4293-A50E-26C4EABC8618 Q28390023-F2509419-E190-4C3B-9A81-9A1FC0546E19 Q28390987-D436FD9D-07C1-4D6B-829A-182F9BA4918E Q28391204-B13760E7-44B9-44FD-BF56-3099553F6A79 Q28391298-4620AA60-981B-4849-9F63-38D6CF815B72 Q28391620-8590FD7C-9527-4D79-B14D-F034C33B1012 Q28391721-2AB21821-0958-4B40-858B-95D19E16056B Q28391747-530F075C-EB18-46BD-BB3B-B99F1E3EC96C Q28393007-DF4A95C5-634F-46A0-B450-35C913A84825 Q28393172-DEB79955-0FC6-4D23-A5EE-CC4A21FCA7DB Q28393661-B5838A1C-37D3-4E0E-B210-75B308401004 Q28393897-FFD3825C-4C7C-4536-88FA-F300D336E69A Q28393898-98AF706C-3E46-4A8A-8542-0988E19C279C Q28394160-7985D2D6-8CB3-4EA8-A3FA-28E2A39103DF Q28395725-2233EEA3-D9C0-48CE-8BCC-946FC5B9F521 Q28396388-9AC78B9E-C7D7-46C6-89E8-D777E284EA20

P2860

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

http://www.wikidata.org/entity/Q23914949

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@ast

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@en

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@en-gb

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@nl

type

label

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@ast

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@en

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@en-gb

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@nl

prefLabel

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@ast

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@en

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@en-gb

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@nl

P1433

Q23914949-C0E397CD-AF9D-4D39-9528-33B924A73190

P1476

Q23914949-FB571AC7-5B94-4F4F-AE10-CBB99F66F22C

P2093

Q23914949-87BEED46-1756-4546-A875-09A9CB5B26A6

Q23914949-E5AD5374-B68F-41E1-BC78-F2550F0F205A

P2860

Q23914949-0A19DF3F-4DE5-4595-9043-5D5F3D157BFA

Q23914949-0A9E89CB-B897-46D6-8F62-547D28AB6939

Q23914949-0B1A77FC-018E-4A44-A472-21449DDEA1D7

Q23914949-1412DF67-0291-4E83-BF4B-47D2E2E459F1

Q23914949-1445DBB1-67C7-4FF8-B57E-82098BAFBCFC

Q23914949-3B9C2D18-A83B-49D0-874F-3C9EECE49C68

Q23914949-44831793-AD42-4883-AD4A-29A42E524CA5

Q23914949-521E4547-E688-4E24-B91F-B34D019E6685

Q23914949-688CCCBC-6883-4FB4-8343-FD4354CB0626

Q23914949-7422AFC8-76E9-48D8-853A-81CAAD409990

P2880

Q23914949-B4AC209E-644C-4101-AC1F-E7E52F85D2B4

P304

Q23914949-C444332E-B884-4DC5-92E9-EE2A4F6E4A42

P31

Q23914949-DA79EC5C-F0C3-4603-BEA7-F389304E7D47

P3181

Q23914949-D518EADA-5615-48AD-AA51-9A992EBB9933

P356

Q23914949-61A9745A-8E79-4E3B-B98B-7FBE9B9BEEA7

P407

Q23914949-72D0809B-E6D1-4AFE-8D1B-0DE70D74A50E

P433

Q23914949-C43C919F-4420-4092-835B-1CE7DF02D1FD

P478

Q23914949-99E776E3-F7E0-45A5-9988-F11779467372

P50

Q23914949-2B737251-39FC-4BA9-B922-DB12BFA1EAD5

Q23914949-5B38F0DF-CB12-4A71-A60A-AC2358103C8F

Q23914949-D5BB6DE6-FF22-4D4C-946D-3F7499F5E5E8

P577

Q23914949-5344EA6B-D98A-4857-AEB3-6CAA532CE083

P5875

Q23914949-3E8BC410-8E5D-455F-8D84-37044C9CBA4B

P698

Q23914949-45E01641-F53F-4A63-B586-D4DD31B6F49B

P859

Q23914949-1AC4EF29-538F-4BBF-AC20-9DC96178674C

P921

Q23914949-4A59699C-90F1-46C6-A925-279778BC5A79

Q23914949-58A43AB7-A851-4DB2-9CC5-5F3AD93DDF16

Q23914949-8EAB6928-4540-421D-977E-2D6B22F62901

Q23914949-B7DB5F41-9D6D-4E51-B14E-141C45BD3D59

P932

Q23914949-E57EE606-CB75-48E2-A80C-AC2B3BE74127

P3181

P356

J.CELLSIG.2007.07.025

P1433

Cellular Signalling

P1476

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

@en

P2093

Jing Fang

http://www.w3.org/2001/XMLSchema#string

Lily Yang

http://www.w3.org/2001/XMLSchema#string

P2860

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

Purification and characterization of phosphoinositide 3-kinase from rat liver

Targeting HIF-1 for cancer therapy

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation

Loss of PTEN facilitates HIF-1-mediated gene expression

PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells

Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate

P2880

20032974

http://www.w3.org/2001/XMLSchema#string

P304

2487-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4783627

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CELLSIG.2007.07.025

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6014556

http://www.w3.org/2001/XMLSchema#string

P698

17826033

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

immune response

chemical reaction

P932

2094004

http://www.w3.org/2001/XMLSchema#string